Patent details

EP2884979 Title: COMBINATION THERAPIES FOR MELANOMA COMPRISING ADMINISTERING COBIMETINIB AND VEMURAFINIB

Basic Information

Publication number:
EP2884979
PCT Application Number:
EP2013067050
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137531315
PCT Publication Number:
WO2014027056
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPIES FOR MELANOMA COMPRISING ADMINISTERING COBIMETINIB AND VEMURAFINIB
French Title of Invention:
THÉRAPIES COMBINÉES POUR MÉLANOME COMPRENANT L'ADMINISTRATION DE COBIMETINIB ET DE VEMURAFENIB
German Title of Invention:
KOMBINATIONSTHERAPIEN FÜR MELANOME MIT VERABREICHUNG VON COBIMETINIB UND VEMURAFINIB
SPC Number:

Dates

Filing date:
15/08/2013
Grant date:
26/06/2019
EP Publication Date:
24/06/2015
PCT Publication Date:
20/02/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/06/2019
EP B1 Publication Date:
26/06/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/08/2019
Expiration date:
15/08/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/06/2019
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:
BRAY, Gordon
Address:
United States (US)

2

Name:
CHAN, Iris, T.
Address:
United States (US)

Priority

1

Priority Number:
201261684673 P
Priority Date:
17/08/2012
Priority Country:
United States (US)

2

Priority Number:
201261705575 P
Priority Date:
25/09/2012
Priority Country:
United States (US)

3

Priority Number:
201261706026 P
Priority Date:
26/09/2012
Priority Country:
United States (US)

4

Priority Number:
201261722725 P
Priority Date:
05/11/2012
Priority Country:
United States (US)

5

Priority Number:
201361780708 P
Priority Date:
13/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/437; A61K 31/4523; A61P 35/00; A61P 35/04; G06Q 30/02; C12Q 1/68; C12Q 1/6886;

Publication

European Patent Bulletin

1

Issue number:
201926
Publication date:
26/06/2019
Description:
Grant (B1)

2

Issue number:
202018
Publication date:
29/04/2020
Description:
Opposition procedure started

3

Issue number:
202221
Publication date:
25/05/2022
Description:
Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages